| Active substance | |
|---|---|
| Dosage | |
| Water Retention | |
| Hepatotoxicity | |
| Lab Test | Monitoring of liver function tests, lipid profiles, and bone density |
| Also known as | |
| Blood pressure | |
| Trade name | |
| FORM | |
| Dosage Unit | |
| ean13 | |
| Reference | |
| Tab Piece | |
| Storage conditions | |
| Chemical name | |
| Formula | |
| Substance class | |
| Main action | Inhibits the enzyme aromatase, preventing the synthesis of estrogen |
| Half-life | |
| Dosage (medical) | |
| Dosage (sports) | Typically 0.5 mg to 2.5 mg daily depending on purpose and cycling needs |
| Effects | Reduces estrogen levels, increases luteinizing hormone and follicle-stimulating hormone levels |
| Side effects | Hot flashes, joint pain, fatigue, increased risk of osteoporosis, nausea |
| Use in sports | Used by bodybuilders and athletes to reduce estrogen levels and increase testosterone levels |
| Packing |
Related products
Aromatase inhibitors
Beligas Pharma Mono- Femara (Letrozole 2.5mg) x 50 tabs Beligas
£83.00
Aromatase inhibitors
£36.00
Aromatase inhibitors
£132.00
Aromatase inhibitors
£45.00
Aromatase inhibitors
£35.00
Aromatase inhibitors
£69.00
Aromatase inhibitors
£106.00
Aromatase inhibitors
£175.00